Scholar Rock Holding Corp to Discuss the SRK-015 TOPAZ Interim Analysis Results Conference Call Transcript
Good day, ladies and gentlemen, and thank you for standing by. Welcome to the SRK-015 TOPAZ Interim Analyst Results Conference Call. (Operator Instructions) After the speakers' presentation, there will be a question-and-answer session. (Operator Instructions)
At this time, I would like to turn the conference over to your host, Ms. Catherine Hu. Thank you. Ma'am, please begin.
Good morning, and thank you for joining us on today's call to review the 6-month interim analysis results from our SRK-015 TOPAZ Phase II clinical trial patients with Type 2 and Type 3 spinal muscular atrophy or SMA. The webcast slides for this call can be accessed on the Events & Presentations section of the Investor Relations page on the Scholar Rock website.
I wanted to note that we'll be making various statements about Scholar Rock's future expectations, plans and prospects that constitute forward-looking statements for the purposes of the safe harbor provisions under the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
